When it comes to heart disease, high blood pressure, high cholesterol and behavioral factors such as smoking and physical inactivity aren't the only culprits. Inflammation also plays a significant role as it triggers and speeds up the build-up of plaque in arteries known as atherosclerosis.

Cardio Diagnostics CDIO, the company leveraging AI to revolutionize cardiovascular disease prevention with precision epigenetics, is awaiting a crucial decision that could be a major factor in the commercial success of its flagship heart disease tests.

Meesha Dogan, PhD, CEO, Co-Founder and Director of Cardio Diagnostics CDIO, was recently a guest on Benzinga's All-Access. Cardio Diagnostics makes cardiovascular disease prevention and early detection more accessible, personalized and precise.